Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00906) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Leptomycin B
|
|||||
| Xenobiotics Type |
Health or Environmental Toxicant(s)
|
|||||
| Classification |
Biotoxin
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6917907"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Induced by This Xenobiotics | ||||||
| Cytochrome P450 3A4 (CYP3A4) | DME Info | Homo sapiens | [1] | |||
| Cellular glutathione peroxidase (GPX1) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev. 2015;2015:217304. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.